X-ZELL launches first Cryophore™ Multiplex Antibody Panels for Cytology Singapore, March 2026 – X-ZELL is proud to announce the commercial launch of its first line of Cryophore™ multiplex antibody panels. Previewed at the 2025 International Congress of Cytology, the...
Early adopters share first-hand experience with Cryoimmunostaining™ technology Halle (Saale), November 2025 – After breaking new ground last year by featuring Cryoimmunostaining™ in the official scientific programme for the first time, the 2025 Seminar on Clinical...
New data confirms routine utility of Cryoimmunostaining™ for effusion and FNA samples Ljubljana, October 2025 – New clinical data on multiplex Cryoimmunostaining™ took centre stage at an international science conference in Ljubljana, Slovenia, where digital cytology...
X-ZELL previews world’s first expert-vetted multiplex panels for cytopathology Florence , May 2025 – X-ZELL is proud to announce the new Cryophore™ range of standardized multiplex antibody panels, developed in close collaboration with leading experts and WHO guideline...
German cytology conference marks historic milestone for multiplex immunostaining Halle, November 2024 — A forward-looking panel discussion on the future of multiplex immunostaining took centre stage at the 2024 Seminar on Clinical Cytology in Pulmonology in Halle,...
